Margaret K Offermann, CEO of OncoSpherix, was a keynote speaker at the 2nd Meridian Drug Discovery Virtual Event. The title of her presentation was “Enhancing chemical properties of dual HIF-1 and HIF-2 inhibitors for treating advanced cancers” https://meridiandrugdiscovery.com
